Thus, understanding the dual impact of the FAT1-YAP1 axis underlying EMT and chromatin dynamics aids in understanding its mechanism in cancer biology and underscores the therapeutic potential of targeting this pathway to disrupt the epigenomic and phenotypic support for tumor progression. This evidence concerns the gene YAP1 and neoplasm.